[Cutaneous Rosai-Dorfman syndrome. Successful therapy with intrralesional corticosteroids].
BACKGROUND
Cutaneous Rosai-Dorfman disease is a rare disorder belonging to the spectrum of non-Langerhans cell histiocytoses. It is characterized by dermal and subcutaneous infiltrates of histiocytes as well as accompanying lymphocytes, plasma cells and granulocytes. Because it is so rare, standard therapies have not been established.


METHODS
A 27-year-old man showed an excellent response to intralesional corticosteroids after unsuccessful prior treatment with methotrexate, systemic steroids and surgery as well as laser therapy.
Hauttumorcentrum der Charité, Klinik für Dermatologie, Venerologie und Allergologie, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Deutschland, staffan.vandersee@charite.de.
S
S
Vandersee
H-J
HJ
Röwert-Huber
S
S
Wöhner
C
C
Loddenkemper
M
M
Beyer
D
D
Humme
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D003872:Dermatitis / Q000188:drug therapy* / Q000473:pathology*; D015618:Histiocytosis, Sinus / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D013577:Syndrome; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones